Union Pacific Railroad is the principal operating company of Union Pacific Corporation (UNP). One of America's most recognized companies, Union Pacific Railroad connects 23 states in the western two-thirds of the country by rail, providing a critical link in the global supply chain. This article discusses the reasons to be bullish on Union Pacific after strong results in July 24, 2014.
Union Pacific has made a strong comeback after the financial crisis and the company�� fundamentals have improved significantly over the last five years. Union Pacific�� diluted earnings per share have increased from $3.74 in 2009 to $9.42 in 2013.
During the same period, the company�� dividend per share has surged to $2.96 from $1.08. Amidst an increase in dividends, the company�� operating cash flow has also increased to $6.8 billion in 2013 from $3.2 billion in 2009.
Union Pacific has also been successful in reducing the company�� debt to capital from 37% in 2009 to 31% in 2013. From a shareholder return perspective, the return on equity has surged to 21.4 in 2013 from 11.8 in 2009.
Hot China Companies To Buy For 2015: Ecolab Inc (ECL)
Ecolab Inc. (Ecolab), incorporated in 1924, develops and markets products and services for the hospitality, foodservice, healthcare and industrial markets. The Company provides cleaning and sanitizing products and programs, as well as pest elimination, equipment maintenance and repair services primarily to customers in the foodservice, food and beverage processing, hospitality, healthcare, government and education, retail, textile care, commercial facilities management and vehicle wash sectors. The Company business segments include United States Cleaning & Sanitizing segment, United States Other Services segment, International segment, Water Services segment, Paper Services segment and Energy Services segment. In April 2013, it acquired Champion Technologies and its related company Corsicana Technologies. In August 2013, Ecolab Inc. sold all the capital equipment design and build business of its Mobotec air emissions control business to The Power Industrial Group.
In March 2011, the Company purchased the assets of O.R. Solutions, Inc. In December 2011, it merged with Nalco Holding Company. In December 2011, the Company acquired Esoform. In December 2011, the Company acquired the InsetCenter pest elimination business in Brazil. In March 2012, it acquired Econ Industria e Comercio de Produtos de Higiene e Limpeza Ltda. On December 1, 2012, the Company's Vehicle Care division was purchased by a wholly owned subsidiary of Zep Inc.
United States Cleaning & Sanitizing Segment
The United States Cleaning & Sanitizing segment consists of six business units, which provide cleaning and sanitizing products and programs to United States markets. The Institutional Division sells specialized cleaners and sanitizers for washing dishes, glassware, flatware, foodservice utensils and kitchen equipment (warewashing), for on-premise laundries (typically used by hotel and healthcare customers) and for general housekeeping functions, as well as food safety products and equipment, dish! washer racks and related kitchen sundries to the foodservice, lodging, educational and healthcare industries. The Institutional Division also provides pool and spa treatment programs for hospitality and other commercial customers, as well as a range of janitorial cleaning and floor care products and programs to customers in hospitality, health care and commercial facilities. The Institutional Division develops and markets various chemical dispensing device systems, which are made available to customers, to dispense its cleaners and sanitizers. In addition, the Institutional Division markets a lease program consisted of dishwashing machines, detergents, rinse additives and sanitizers, including full machine maintenance.
The Food & Beverage division addresses cleaning and sanitation at the beginning of the food chain to facilitate the processing of products for human consumption. The Division provides detergents, cleaners, sanitizers, lubricants and animal health products, as well as cleaning systems, electronic dispensers and chemical injectors for the application of chemical products, primarily to dairy plants, dairy farms, breweries, soft-drink bottling plants, and meat, poultry and other food processors. The Food & Beverage Division is also a developer and marketer of antimicrobial products used in direct contact with meat, poultry, seafood and produce during processing in order to reduce microbial contamination. The Food & Beverage Division also designs, engineers and installs clean-in-place (CIP) process control systems and facility cleaning systems for its customer base.
Ecolab�� Kay business unit supplies cleaning and sanitizing chemical products and related items primarily to regional, national and international quick service restaurant (QSR) chains and to regional and national food retailers (supermarkets and grocery stores). Its products include specialty and general purpose hard surface cleaners, degreasers, sanitizers, polishes, hand care products and assorted clea! ning tool! s and equipment, which are primarily sold under the Kay and Ecolab brand names. Kay supports its product sales with employee training programs and technical support designed to meet the needs of its customers.
Both Kay�� QSR business and its food retail business utilize a corporate account sales force, which establishes relationships and negotiates contracts with customers at the corporate headquarters and regional office levels and a field sales force, which provides program support at the individual restaurant or store level. Customers in the QSR market segment are primarily supplied through third-party distributors. The Healthcare Division provides infection prevention and other healthcare related offerings to acute care hospitals, surgery centers, dental offices and veterinary clinics. The Healthcare Division�� infection prevention products (hand hygiene, hard surface disinfectants, instrument cleaners, patient drapes, fluid control and equipment drapes) are sold primarily under the Ecolab and Microtek brand names to various departments within the acute care environment (Infection Control, Environmental Services, Central Sterile and Operating Room).
The Textile Care Division provides chemical laundry products and dispensing systems, as well as related programs, to large industrial and commercial laundries. The Textile Care Division�� customers include free-standing laundry plants used by institutions, such as hotels, restaurants and healthcare facilities, as well as industrial and textile rental laundries. Products and programs include laundry cleaning and specialty products, related dispensing equipment, plus water and energy management. The Vehicle Care Division provides vehicle appearance products, which include soaps, polishes, sealants, wheel and tire treatments and air fresheners. Products are sold to vehicle rental, fleet and consumer car wash and detail operations. Brand names utilized by the Vehicle Care Division include Blue Coral, Black Magic and Rain-X.
United States Other Services Segment
The United States Other Services segment consists of two business units: Pest Elimination and Equipment Care. The Pest Elimination Division provides services designed to detect, eliminate and prevent pests, such as rodents and insects, in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations and other institutional and commercial customers. Equipment Care Division provides equipment repair and maintenance services for the commercial food service industry. Repair services are offered for in-warranty repair, acting as the manufacturer�� authorized service agent, as well as after warranty repair. In addition, Equipment Care operates as a parts distributor to repair service companies and end use customers.
International Segment
The Company conducts business in approximately 74 countries outside of the United States through wholly owned subsidiaries or, in the case of Venezuela, through joint ventures with local partners. In other countries, selected products are sold by the Company�� export operations to distributors, agents or licensees. Its International operations are located in Europe, Asia Pacific, Latin America and Canada, with smaller operations in Africa and the Middle East.
Water Services and Paper Services Segments
The Water and Process Services business consist of two segments: Water Services, which focuses on customers across industrial and institutional markets, and Paper Services, serving the pulp and paper industries. It serve customers in the aerospace, chemical, pharmaceutical, mining and primary metals, power, food and beverage, medium and light manufacturing and pulp and papermaking industries as well as institutional clients such as hospitals, universities, commercial buildings and hotels. The Paper Services segment offers a portfolio of programs that are used in all principal steps of the papermak! ing proce! ss and across all grades of paper, including graphic grades, board and packaging, and tissue and towel.
It provides water treatment capabilities to a range of industries. The water treatment applications include cooling water applications, boiler water applications, raw water/potable water preparation, wastewater applications and water reuse and recycling. Its cooling water treatment programs are designed to control the main problems associated with cooling water systems, such as corrosion, scale and microbial fouling and contamination in open recirculating, once-through and closed systems. Its three dimensional (3D) TRASAR technology for cooling water is automated system for simultaneous control of corrosion, scale and microbial fouling and contamination. It also provides pulp and papermaking applications.
Energy Services Segment
The Energy Services Division provides on-site, technology-driven solutions to the global drilling, oil and gas production, refining, and petrochemical industries. In addition to recovery, production and process enhancements, it delivers a range of water treatment offerings to refineries and petrochemical plants. The Energy Services Division is divided into an Upstream group composed of its Adomite, Oil Field Chemicals and Enhanced Oil Recovery businesses and a Downstream refinery and petrochemical processing service business.
The Adomite group offers a range of product solutions. It supplies chemicals for the cementing, drilling, fracturing and acidizing phases of well drilling and stimulation. The Oilfield Chemicals business provides solutions to the oil and gas production sector. It focuses in crude oil and natural gas production, pipeline gathering/transmission systems, gas processing, and heavy oil and bitumen upgrading. TIORCO business globally markets custom-engineered chemical solutions. Its services include reservoir screening, target validation, laboratory and reservoir simulation work, secondary flood optimization! , tertiar! y recovery flood design and implementation and when needed, a produced water treatment solution. It provide total water management solutions to customers��refining and chemical processing needs, including boiler treatment, cooling water treatment and wastewater treatment.
Advisors' Opinion:- [By Doug Ehrman]
While most of us take water pretty much for granted, cleaning it and making it safe is big business that could spell significant profits for investors. Ecolab (NYSE: ECL ) , the world's largest provider of services and chemicals used in water treatment, recently announced its plans to expand across the globe. Similarly, despite the depressed prices we have seen for rare earth materials, Molycorp (NYSE: MCP ) is finding a measure of success in water treatment.
Top 5 Railroad Companies To Buy Right Now: Shire PLC (SHPG)
Shire plc (Shire), incorporated on January 28, 2008, is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in other therapeutic areas. As of December 31, 2012, the Company�� products included VYVANSE/VENVANSE (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) modified release (XL), LIALDA (mesalamine)/ MEZAVANT(mesalazine), PENTASA (mesalamine), RESOLOR (prucalopride), FOSRENOL (lanthanum carbonate), XAGRID (anagrelide hydrochloride), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant) and DERMAGRAFT(Human Fibroblast-Derived Dermal Substitute). As of December 31, 2012, the Company�� products under development included INTUNIV (extended release guanfacine), VYVANSE/VENVANSE (lisdexamfetamine dimesylate), INTUNIV, Guanfacine Carrier Wave, LIALDA (mesalamine)/MEZAVANT (mesalazine), RESOLOR (prucalopride), RESOLOR (prucalopride), SPD 557(M0003), XAGRID, VYVANSE (lisdexamfetamine dimesylate), REPLAGAL (agalsidase alfa), HGT-4510, HGT-2310, HGT-1410, HGT-1110, HGT-3010, and DERMAGRAFT. On January 31, 2012, the United States Food and Drug Administration approved VYVANSE for the maintenance treatment of ADHD in adults. In March 2013, it announced the acquisition Of Premacure AB. In January 2014, Shire Plc sold its DERMAGRAFT assets to Organogenesis Inc. In January 2014, Shire Plc acquired 79.5% interest in ViroPharma Inc.
VANSE/ VENVANSE
VYVANSE is a New Chemical Entity (NCE) and is the pro-drug stimulant for the treatment of ADHD, where the amino acid l-lysine is linked to d-amphetamine. VYVANSE is therapeutically inactive until metabolized in the body. The United Stat! es Food and Drug Administration approved VYVANSE as a once-daily treatment for children aged 6 to 12 with ADHD in February 2007, for adults in April 2008 and for adolescents aged 13 to 17 in November 2010. VYVANSE is available in the United States in six dosage strengths: 20 milligram, 30 milligram, 40 milligram, 50 milligram, 60 milligram and 70 milligram. Health Canada approved VYVANSE for the treatment of ADHD in pediatric patients aged 6 to 12 in February 2009, and for adolescents and adults in November 2010. In April 2012, ANVISA, the Brazilian health authority, granted marketing authorization approval for lisdexamfetamine dimesylate for the treatment of ADHD in children aged 6-12.
ADDERALL XR
ADDERALL XR is an extended release treatment for ADHD, which uses MICROTROL drug delivery technology and is designed to provide once-daily dosing. It is available in 5 milligram, 10 milligram, 15 milligram, 20 milligram, 25 milligram and 30 milligram capsules and can be administered either as a capsule or sprinkled on soft food. The United States Food and Drug Administration has approved ADDERALL XR as a once-daily treatment for children aged 6 to 12 with ADHD, for adults in and for adolescents aged 13 to 17. Teva Pharmaceutical Industries, Ltd. (Teva) and Impax Laboratories, Inc. (Impax) commenced commercial shipment of their authorized generic versions of ADDERALL XR in April and October 2009, respectively. Shire receives royalties from Impax�� sales of authorized generic ADDERALL XR.
INTUNIV
INTUNIV is a selective alpha-2A receptor agonist indicated for the treatment of ADHD. Alpha-2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signalling in the prefrontal cortex (Cell. 2007; 129:397-410). INTUNIV is non-scheduled and has no known potential for abuse or dependence. The United States Food and Drug Administration approved INTUNIV in September 2009, as a once-daily monotherapy treatment of ADHD in children and adolesce! nts aged ! 6 to 17. It is available in 1 milligram, 2 milligram, 3 milligram and 4 milligram tablets.
EQUASYM
Shire has acquired from UCB the worldwide rights (excluding the United States, Canada and Barbados) to EQUASYM (methylphenidate hydrochloride) IR and XL for the treatment of ADHD in children and adolescents aged 6 to 18. At December 31, 2012,EQUASYM XL was commercially available in 10 countries in 10mg, 20mg and 30mg strengths. EQUASYM XL is marketed in Mexico and South Korea under the trade name METADATE CD.
LIALDA/MEZAVANT
LIALDA is indicated for the induction ofmild to moderately active UC and for the maintenance of remission of UC. The addition of the indication for maintenance of remission of ulcerative colitis was approved by Health Canada in February 2011, and by the United States Food and Drug Administration in July 2011. LIALDA is once-daily oral formulation of mesalamine indicated for the induction and maintenance of remission. As of December 31, 2012, LIALDA/MEZAVANT (this product is marketed outside the United States as MEZAVANT) was commercially available in 19 countries either directly or through distributor arrangements.
PENTASA
PENTASA controlled release capsules are approved in the United States (marketed by Shire in the United States and by Ferring outside of the United States) and indicated for the induction of remission and for the treatment of patients with mild to moderately active ulcerative colitis. PENTASA is an ethylcellulose-coated, controlled release capsule formulation designed to release therapeutic quantities of mesalamine throughout the gastrointestinal tract. PENTASA is available in the United States in 250 milligram and 500 milligram capsules.
RESOLOR
RESOLOR (prucalopride), a 5-HT4 receptor agonists that stimulates gastrointestinal motility and acts primarily on different parts of the lower gastrointestinal tract (enterokinetic). In October 2009, RESOLOR was appr! oved by t! he EMA throughout the European Union as a once daily oral treatment for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. In July 2010, Swissmedic granted RESOLOR marketing authorization in Switzerland for the treatment of idiopathic chronic constipation in adults. RESOLOR is available in milligram and 2 milligram dose strengths, both for once-daily dosing. At December 31, 2012, RESOLOR was available in six European Union countries. Formulated as a chewable tablet, FOSRENOL is available in 500 milligram, 750 milligram and 1,000 milligram dosage strengths.
XAGRID
XAGRID (anagrelide hydrochloride) is marketed in Europe for the reduction of elevated platelet counts in at-risk ET patients. XAGRID has been granted orphan drug status in the European Union. In the United States, anagrelide hydrochloride is sold by the Company under the name AGRYLIN for the treatment of thrombocythemia secondary to a MPD.
REPLAGAL
REPLAGAL is for the treatment of Fabry disease. Fabry disease is a genetic disorder resulting from a deficiency in the activity of the lysosomal enzyme alpha-galactosidase A, which is involved in the breakdown of fats. REPLAGAL is a human alpha-galactosidase A protein made in human cells that replaces the deficient alpha-galactosidase A with an active enzyme to ameliorate certain clinical manifestations of Fabry disease. At December 31, 2012, REPLAGAL was approved in 46 countries.
ELAPRASE
ELAPRASE is a treatment for Hunter syndrome (also known as Mucopolysaccharidosis Type II or MPS II). Hunter syndrome is a genetic disorder mainly affecting males that interferes with the body's ability to break down and recycle waste substances called mucopolysaccharides, also known as glycosaminoglycans (GAGs). ELAPRASE was approved by the United States Food and Drug Administration and granted marketing authorization by the EMA for the long term treatment of patients with Hunter ! syndrome.! ELAPRASE has been granted orphan drug by both the United States Food and Drug Administration and the EMA. ELAPRASE received approval from the Ministry of Health, Labour and Welfare in Japan. At December 31, 2012, ELAPRASE was approved in 51 countries.
VPRIV
VPRIV is a treatment for Type 1 Gaucher disease. Gaucher disease is an inherited genetic disorder, which results in a deficiency of the lysosomal enzyme beta-glucocerebrosidase. VPRIV was approved by the United States Food and Drug Administration in February 2010, for the long-term treatment of patients with Type 1 Gaucher disease. The EMA approved the marketing authorization for the use of VPRIV in August 2010. VPRIV was authorized as an orphan medicine through the Centralised Procedure in Europe. At December 31, 2012, VPRIV was approved in 38 countries.
FIRAZYR
FIRAZYR is a peptide-based therapeutic developed for the symptomatic treatment of acute attacks of HAE. In July 2008 the EMA granted marketing authorization throughout the European Union for the use of FIRAZYR for the symptomatic treatment of acute attacks of HAE, and in May 2011 approved FIRAZYR for self-administration after training in subcutaneous injection technique by a healthcare professional. In August 2011, the United States Food and Drug Administration granted marketing approval for FIRAZYR in the United States for treatment of acute attacks of HAE in adults aged 18 and older. After injection training, patients may self-administer FIRAZYR. FIRAZYR has been granted orphan drug by both the United States Food and Drug Administration and the EMA. At December 31, 2012, FIRAZYR was approved in 38 countries globally.
DERMAGRAFT
DERMAGRAFT is a bio-engineered skin substitute that assists in restoring damaged tissue. DERMAGRAFT is indicated for use in the treatment of full-thickness Diabetic foot ulcers (DFU) greater than six weeks in duration, which extend through the dermis, but without tendon, muscle, joint capsu! le, or bo! ne exposure. DERMAGRAFT is approved by the United States Food and Drug Administration as a Class III medical device for the treatment of DFUs. DERMAGRAFT is also approved for the treatment of DFUs in South Africa, Israel and Singapore.
The Company competes with Shionogi & Co., Ltd., Janssen-Cilag, Novartis, Medice, Eli Lilly, Warner Chilcott, Synergy Pharmaceuticals, Inc., ARYx Therapeutics, Theravance, Inc., Sucampo Pharmaceuticals, Inc., Albireo, Actelion Ltd., Protalix BioTherapeutics Inc, Genzyme, CSL Behring, Pharming Group N.V., ViroPharma, Dyax Corporation, Organogenesis, Healthpoint, Soluble System, KCI, Smith & Nephew, Aurobindo and Apotex.
Advisors' Opinion:- [By MONEYMORNING.COM]
Several recent high-profile tax inversions, such as AbbVie Inc.'s (NYSE: ABBV) merger with Ireland-based Shire Plc. (Nasdaq ADR: SHPG) and Medtronic Inc.'s (NYSE: MDT) deal to buy Ireland-based Covidien Plc. (NYSE: COV), have resulted in much wailing and gnashing of teeth in our nation's capital.
- [By Eddie Staley]
AbbVie (NYSE: ABBV) lifted its offer to buy Shire plc (NASDAQ: SHPG) to 30.1 billion pounds ($51.3 billion).
The latest offer for Shire is approximately an 11 percent increase from the previous bid. The new offer stands at £22.44 cash and 0.8568 AbbVie shares for each Shire share, or £51.15 total.
- [By Anna Prior]
U.S. drug giant Abbvie is close to clinching a deal to buy Dublin-based Shire (SHPG) PLC for more than $53 billion, in what would be one of the largest so-called inversion deals through which U.S. companies are seeking a lower corporate tax burden. Shire American depositary shares rose 1.7% to $253.17, while Abbvie shares slipped 2.7% to $53.50 premarket.
Top 5 Railroad Companies To Buy Right Now: Mechel Steel Group OAO (MTL)
Mechel OAO, together with its subsidiaries, engages in mining and steel businesses in the Russian Federation, other CIS countries, Europe, Asia, the Middle East, the United States, and internationally. The company operates through four segments: Mining, Steel, Ferroalloys, and Power. The Mining segment engages in the production and sale of metallurgical and steam coal, coke, iron ore, and limestone, as well as chemical products, such as coal tar, naphthalene, and other compounds. The Steel segment produces and sells semi-finished steel products, carbon and special long products, and carbon and stainless flat products, as well as metal products, including wire products, forgings, and stampings. The Ferroalloys segment is involved in the production and sale of nickel ore, low-ferrous ferronickel, ferrochrome, and ferrosilicon. The Power segment engages in the generation and sale of electricity and heat energy from steam coal; and power distribution activities. The company, f ormerly known as Mechel Steel Group OAO, was founded in 2003 and is based in Moscow, the Russian Federation.
Advisors' Opinion:- [By Lisa Levin]
Mechel OAO (NYSE: MTL) shares reached a new 52-week low of $1.57. Mechel's trailing-twelve-month revenue is $120.84 million.
Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets
Top 5 Railroad Companies To Buy Right Now: FAB Universal Corp (FU)
FAB Universal Corp.(FAB), formerly Wizzard Software Corporation, incorporated on July 1, 1998, operates in two segments: Software and Media Services. The Software segment engages primarily in the development, sale, and service of custom and packaged computer software products. The Media Services provides podcast hosting, content management tools and advertising services. The Company�� software segment attributes revenues from the development, sale, and service of custom and packaged computer software products at the time the product is shipped and collections are likely and from digital media publishing services at the time the service is provided. Its media segment attributes revenue from digital media publishing service at the time the service is provided and collection is likely. As of September 30, 2012, the Company does not have any inter-segment revenues. On October 12, 2012, it opened a 20,000 square foot Flagship superstore in the Beijing shopping district of SoShow. On September 26, 2012, the Company completed the acquisition of Digital Entertainment International Ltd. (DEI). As of September 30,2012, the Company discontinued its Future Healthcare of America (FHA).
The Company specializes in the distribution of entertainment and audio visual products through its two flagship stores in Beijing as well as its online stores. DEI, through its wholly owned subsidiary and its VIE, is engaged in marketing and distributing various officially licensed digital entertainment products under the FAB brand, including products such as digital music files, Compact Discs(CD), Video Compact Discs (VCD) and Digital Video Disks (DVD) as well as books, magazines, mobile phone accessories and cameras. DEI�� products and services are primarily distributed through its flagship stores, wholesale services, FAB kiosks, and online virtual stores. FAB kiosks, located in high-traffic areas of office buildings, shopping malls, retail stores and airports, are self-service terminals that provide a range of en! tertainment and consumer applications. Its Media is primarily engaged in operating and providing multimedia kiosks for music downloads information exchange and advertising.
MEDIA
The Company distributes over 150,000 media based products including copyrighted DVD��, Blu-ray Discs, music CD��, video games and downloadable digital content through three distribution channels: wholesale and retail, licensing and kiosks. It conducts their retail business through their flagship stores. Each store has over 20,000 square feet in size and carries the selection of copyrighted audio and video products in China, including CDs, VCDs, DVDs, blu-rays, books, magazines and portable electronic devices. It markets their products to individual consumers and audio-video retailers. The flagship stores are recognized by many Chinese consumers as the right place to buy copyright protected products. Celebrity signing events are the driver to FAB�� retail stores which have been used as a venue for Chinese music and movie stars to meet their fans. Its SoShow flagship provides Beijing shoppers with its audio-video hypermarket. As a preferred venue for product announcements, publishing parties, studio releases, author readings, movie showings, live promotional performances and concerts, its SoShow outlet is one of China�� ultra-modern entertainment destination for music lovers, film buffs, game enthusiasts, and early electronic adopters.
The Company's wholesale distribution provides audio-video products such as compact discs, video compact discs and digital video discs as well as books and magazines to audio-video products retailers. It distributes these media products to over 80 customers including Sohu (NASDAQ: SOHU), Dangdang (NYSE: Dang) and Century Outstanding Information Technology Company, a subsidiary of Amazon.com (NASDAQ: AMZN). Its wholesale business caters to three types of customers: retail stores, FAB license stores and small wholesale/resellers. Customers place orders by! telephon! e, through the Internet or in-person and fulfillment is handled by its vehicle fleet or through direct warehouse access. As of September 30, 2012, the Company has over 100 suppliers and 80 wholesale customers, including the Government.
Its Intelligent Media Kiosks are based on 61 national intellectual property rights, are automated teller machine (ATM) style terminals where consumers can download copyrighted music, video games, ringtones, digital books and movies directly to their cell phones, memory sticks or other mobile storage devices. Its Media Kiosks can also run video ads on the high-tech liquid crystal display (LCD) screens and accept payments for utility bills, metro cards, and credit card bills. It is a self-service vending kiosk designed and launched by the Company. The kiosks target the millions of mobile and portable device users combing interactive touch screen and LED display with a selection of copyrighted content such as music, movies and games. There are thousands of licensed digital entertainment content items in each kiosk, such as music, movie and TV episodes, which allows the customer to play or download to their portable device or memory card with payment by cash, its membership card or ATM card. It has deployed over 11,000 kiosks through their licensing program. The kiosks are located in high-traffic areas, such as office buildings, shopping malls, and retail stores. It generates revenues from its Intelligent Media Kiosk business through the sale of licenses and then through ongoing media content download, media membership card sales and kiosk-based advertising.
SPEECH TECHNOLOGY & SERVICES GROUP
Its legacy Speech Technology & Services Group sells and licenses speech programming tools, related speech products and services, and distributable speech engines in over 13 languages worldwide. It receives the majority of its sales leads through arrangements with AT&T, as well as through its own Internet marketing efforts through Google, Yahoo and! other In! ternet search engines. The Speech Technology and Services Group's immediate focus is to increase revenue and be a preferred supplier for speech technologies to businesses worldwide, emphasize great technologies, competitive prices, and support to the speech development community and offer non-technical hosted speech conversion services to companies.
Advisors' Opinion:- [By Jayson Derrick]
Shares of FAB Universal (NYSE: FU) have been halted premarket, and remained as such throughout the duration of the trading day. There is no indication when shares would resume trading.
- [By Sally Jones]
Here’s a look at three application software companies currently on a 52-week low and still held by a few billionaires. The9 Ltd. (NCTY), Merge Healthcare Inc. (MRGE) and FAB Universal Corp. (FU) are more than 52% off a 52-week high.
- [By Bryan Murphy]
If history is any indication, than roughly half of you are about to hate me for what I'm about to say regarding Fab Universal Corp. (NYSEMKT:FU), while the other half of anyone reading this will likely love me for it - there is no in between. Here goes... FU is poised to make a fairly significant pullback following last week's heroic rally.
No comments:
Post a Comment